Octopus Investments has opened a new £20m fundraise for its two Alternative Investment Market venture capital trusts.
The VCTs offer exposure to investments across a range of sectors, from building materials and pharmaceuticals to software development, with businesses at different stages of maturity. One of the companies in the portfolio is testing laboratories firm Diaceutics, which provides the world's leading pharmaceutical companies with an end-to-end solution for the launch of precision medicine diagnostics. Another growth company backed by the AIM VCTs is Learning Technologies Group, a group of businesses who provide innovative learning technology solutions. VCTs prove resilient against wi...
To continue reading this article...
Join Investment Week for free
Signup and gain exclusive members-only insights - all free of charge!
- Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
- Get ahead of regulatory and technological changes affecting fund management
- Important and breaking news stories selected by the editors delivered straight to your inbox each day
- Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
- Be the first to hear about our extensive events schedule and awards programmes
